Published in Am J Physiol Renal Physiol on February 17, 2004
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol (2007) 1.21
Intrarenal dopaminergic system regulates renin expression. Hypertension (2009) 1.17
Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta (2010) 1.13
Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice. Pediatr Nephrol (2008) 1.07
Dopamine receptors: important antihypertensive counterbalance against hypertensive factors. Hypertension (2010) 1.06
Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens (2009) 1.02
Caveolin-1 and dopamine-mediated internalization of NaKATPase in human renal proximal tubule cells. Hypertension (2009) 0.98
Lack of renal dopamine D5 receptors promotes hypertension. J Am Soc Nephrol (2010) 0.98
Intrarenal dopamine attenuates deoxycorticosterone acetate/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway. Hypertension (2009) 0.89
H2O2 stimulation of the Cl-/HCO3- exchanger by angiotensin II and angiotensin II type 1 receptor distribution in membrane microdomains. Hypertension (2008) 0.87
Oxidative stress and alpha1-adrenoceptor-mediated stimulation of the Cl-/HCO3- exchanger in immortalized SHR proximal tubular epithelial cells. Br J Pharmacol (2008) 0.83
Renal dopaminergic system: Pathophysiological implications and clinical perspectives. World J Nephrol (2015) 0.79
Regulation of blood pressure, oxidative stress and AT1R by high salt diet in mutant human dopamine D5 receptor transgenic mice. Hypertens Res (2015) 0.78
Short-term regulation of the Cl-/HCO3(-) exchanger in immortalized SHR proximal tubular epithelial cells. Biochem Pharmacol (2008) 0.77
Short telomeres and prognosis of hypertension in a chinese population. Hypertension (2009) 2.18
G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A (2002) 1.87
Multilocus analysis of hypertension: a hierarchical approach. Hum Hered (2004) 1.82
The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4. Mol Pharmacol (2005) 1.75
Renal D3 dopamine receptor stimulation induces natriuresis by endothelin B receptor interactions. Kidney Int (2008) 1.63
Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis. Hypertension (2013) 1.57
Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem (2006) 1.51
Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol (2014) 1.50
RhoA modulates Smad signaling during transforming growth factor-beta-induced smooth muscle differentiation. J Biol Chem (2005) 1.48
Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol (2006) 1.40
Role of Gα(12)- and Gα(13)-protein subunit linkage of D(3) dopamine receptors in the natriuretic effect of D(3) dopamine receptor in kidney. Hypertens Res (2011) 1.40
Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res (2006) 1.36
Functional genomics of the dopaminergic system in hypertension. Physiol Genomics (2004) 1.32
D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol (2006) 1.32
Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest (2008) 1.31
Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension (2012) 1.30
D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int (2004) 1.28
Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci (2002) 1.25
Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension (2006) 1.22
Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension (2005) 1.22
Genetics of salt-sensitive hypertension. Curr Hypertens Rep (2011) 1.21
Diagnostic tools for hypertension and salt sensitivity testing. Curr Opin Nephrol Hypertens (2013) 1.21
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol (2007) 1.21
Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem (2002) 1.20
RGC-32 mediates transforming growth factor-beta-induced epithelial-mesenchymal transition in human renal proximal tubular cells. J Biol Chem (2009) 1.18
Galpha12- and Galpha13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension (2003) 1.17
Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats. Hypertension (2003) 1.16
Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int (2002) 1.16
Response gene to complement 32, a novel regulator for transforming growth factor-beta-induced smooth muscle differentiation of neural crest cells. J Biol Chem (2007) 1.16
Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension (2006) 1.15
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy. Epilepsy Res (2010) 1.14
Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives. J Med Chem (1999) 1.14
Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment. Eur J Clin Pharmacol (2007) 1.12
Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension (2008) 1.11
Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension. Am J Clin Nutr (2010) 1.11
Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension (2005) 1.08
Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension (2008) 1.07
Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice. Pediatr Nephrol (2008) 1.07
G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor. J Biol Chem (2009) 1.06
The dopaminergic system in hypertension. Clin Sci (Lond) (2007) 1.06
Dopamine and renal function and blood pressure regulation. Compr Physiol (2011) 1.06
Dopamine receptors: important antihypertensive counterbalance against hypertensive factors. Hypertension (2010) 1.06
Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci (2002) 1.04
Apical and basal uptake of L-dopa and L-5-HTP and their corresponding amines, dopamine and 5-HT, in OK cells. Am J Physiol (1997) 1.04
The regulation of proximal tubular salt transport in hypertension: an update. Curr Opin Nephrol Hypertens (2009) 1.03
Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens (2009) 1.02
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol Scand (2009) 1.01
Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21. J Hypertens (2011) 1.00
Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension (2012) 0.99
Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine. Epilepsia (2001) 0.99
Lack of renal dopamine D5 receptors promotes hypertension. J Am Soc Nephrol (2010) 0.98
Caveolin-1 and dopamine-mediated internalization of NaKATPase in human renal proximal tubule cells. Hypertension (2009) 0.98
Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J Mol Cell Biol (2013) 0.98
Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine. Br J Pharmacol (2002) 0.98
Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res (2001) 0.98
Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of SHR. Hypertension (2002) 0.97
Deamination of newly-formed dopamine in rat renal tissues. Br J Pharmacol (1991) 0.97
Renal dopaminergic defect in C57Bl/6J mice. Am J Physiol Regul Integr Comp Physiol (2009) 0.97
Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension (2012) 0.97
Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease. Methods Mol Biol (2008) 0.96
Renal dopamine receptors, oxidative stress, and hypertension. Int J Mol Sci (2013) 0.96
The elevated blood pressure of human GRK4gamma A142V transgenic mice is not associated with increased ROS production. Am J Physiol Heart Circ Physiol (2007) 0.95
Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2008) 0.95
Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor. Endocrinology (2011) 0.95
Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice. Hypertension (2010) 0.95
Role of GRK4 in the regulation of arterial AT1 receptor in hypertension. Hypertension (2013) 0.95
Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation. Mol Pharmacol (2006) 0.94
Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase. Free Radic Biol Med (2012) 0.94
Gialpha3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event. Am J Physiol Renal Physiol (2004) 0.94
Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass. Am J Physiol Renal Physiol (2012) 0.93
Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats. J Hypertens (2012) 0.93
Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension (2004) 0.93
Angiotensin II type 1 receptor blocker attenuates the activation of ERK and NADPH oxidase by mechanical strain in mesangial cells in the absence of angiotensin II. Am J Physiol Renal Physiol (2009) 0.93
Role of cAMP-PKA-PLC signaling cascade on dopamine-induced PKC-mediated inhibition of renal Na(+)-K(+)-ATPase activity. Am J Physiol Renal Physiol (2002) 0.93
Rat strain effects of AT1 receptor activation on D1 dopamine receptors in immortalized renal proximal tubule cells. Hypertension (2005) 0.92
Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.92
Response gene to complement 32 interacts with Smad3 to promote epithelial-mesenchymal transition of human renal tubular cells. Am J Physiol Cell Physiol (2011) 0.92
C-terminal di-leucine motif of dopamine D₁ receptor plays an important role in its plasma membrane trafficking. PLoS One (2011) 0.92
Dopamine D3 receptor-mediated inhibition of Na+/H+ exchanger activity in normotensive and spontaneously hypertensive rat proximal tubular epithelial cells. Br J Pharmacol (2004) 0.91
Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats. Hypertension (2005) 0.91
Impaired endothelial function and microvascular asymmetrical dimethylarginine in angiotensin II-infused rats: effects of tempol. Hypertension (2010) 0.91
D1-like receptors regulate NADPH oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells. Hypertension (2009) 0.91
Rab4 and Rab11 coordinately regulate the recycling of angiotensin II type I receptor as demonstrated by fluorescence resonance energy transfer microscopy. J Biomed Opt (2008) 0.91
Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure. PLoS One (2012) 0.90
High body mass index is an important risk factor for the development of type 2 diabetes. Intern Med (2012) 0.90
G protein-coupled receptor kinase 4: role in blood pressure regulation. Hypertension (2008) 0.90
D3 dopamine receptor directly interacts with D1 dopamine receptor in immortalized renal proximal tubule cells. Hypertension (2006) 0.90
Inhibitory effect of ETB receptor on Na(+)-K(+) ATPase activity by extracellular Ca(2+) entry and Ca(2+) release from the endoplasmic reticulum in renal proximal tubule cells. Hypertens Res (2009) 0.89
D5 dopamine receptor decreases NADPH oxidase, reactive oxygen species and blood pressure via heme oxygenase-1. Hypertens Res (2013) 0.89
Effects of 6-hydroxydopamine on dopamine and noradrenaline content in dog blood vessels and heart. Evidence for a noradrenaline-independent dopamine pool. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.89
Response gene to complement 32 is essential for fibroblast activation in renal fibrosis. J Biol Chem (2011) 0.89
Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate. Int J Clin Pharmacol Ther (2008) 0.89
Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 19-6327 on the deamination of newly formed dopamine in the rat kidney. J Pharmacol Exp Ther (1990) 0.89
Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats. Hypertens Res (2008) 0.89
D5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol (2005) 0.89
A comparison between the pattern of dopamine and noradrenaline release from sympathetic neurones of the dog mesenteric artery. Br J Pharmacol (1987) 0.88
Effect of food on the pharmacokinetic profile of trans-resveratrol. Int J Clin Pharmacol Ther (2008) 0.88
A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy. Clin Chim Acta (2013) 0.88
Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells. Hypertension (2013) 0.88